squamous cell carcinoma Clinical Research Trials

Please select a valid location from the dropdown

Found 753 clinical trials

Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery

This is an investigator-initiated, single-arm, single-center, exploratory clinical study.The study population consisted of patients with R0 resection of esophageal squamous cell carcinoma who

0 views
13 Feb, 2021
1 location

Survival Benefit of Elective Neck Dissection in T1 2N0M0 Oral Squamous Cell Carcinoma

Controversy over surgical treatment of clinically negative neck in early stage oral squamous cell carcinoma revolves around the uncertainty of its impact on patient prognosis. The efficacy of

4 views
21 Jan, 2021
2 locations

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

In France, the incidence of head and neck squamous cell carcinomas (HNSCC) is 16 000 new cases/year. During these last years, many new chemotherapies and targeted therapies have been developed

1 views
08 Nov, 2020

Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma

for head and neck squamous cell carcinoma (HNSCC). Additional objectives include assessment of patient-reported quality of life data, pain parameters and dermatologic quality of life responses. The

2 views
24 Jan, 2021
1 location

Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)

Cabozantinib in patients with advanced penile squamous cell carcinoma (PSCC): an open-label, single-center, phase 2, single-arm trial (CaboPen)

0 views
03 Mar, 2021
1 location

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

The purpose of this study is to determine the 1-year rate of locoregional disease control in the experimental arm, using a control arm to avoid selection bias.

15 views
07 Nov, 2020
1 location

A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma

suggested synergy between nimotuzumab, paclitaxel, cisplatin and radiation. For our phase II study in locally advanced esophageal squamous cell carcinoma (ESCC), the combination of cetuximab and

0 views
21 Jan, 2021
12 locations

Trial of Docetaxel Cisplatin Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

This phase I/II study is being conducted to determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and efficacy of a combination chemotherapy using docetaxel, cisplatin and 5-fluorouracil (DCF) in unresectable advanced esophageal cancer. The usefulness of the this regimen is evaluated by RECIST, time to progression and median survival time.

ct scan

combination chemotherapy

platelet count

measurable disease

recurrent esophageal cancer

9 views
07 Nov, 2020
1 location

Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

This study evaluated the effectiveness and safety of sintilimab combined with cCRT in patients with locally advanced ESCC.

0 views
25 Jan, 2021
1 location

Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

The purpose of this study is to evaluate the safety and efficacy of IBI318 (anti-PD-1/PD-L1) in adult participants with metastatic (nodal or distant) cutaneous squamous cell carcinoma (CSCC), or

0 views
27 Jan, 2021
1 location

Filter By

Found 753 clinical trials